论文部分内容阅读
自1954年Francois报告局部应用皮质类固醇制剂(以下简称类固醇)发生青光眼以来,经过大量的临床观察与实验研究,对该病现今已有了进一步认识。本文将这方面的部分国外文献进行综述,以供临床参考。一、类固醇性高眼压反应: 作者们大多以0.1％倍他米松(Betamethasone)或0.1％地塞米松(氟美松)溶液,每日4次滴眼,观察2周至2月左右,如眼压升高至20mmHg以上,或较用药前升高5mmHg者均称为类固醇眼压反应阳性。则原发性开角青光眼,据Armaly等报告几乎全部病例为阳性,这种高眼压反应无
Since 1954, Francois reported that topical application of corticosteroid preparations (hereinafter referred to steroid) glaucoma, after a large number of clinical observations and experimental studies, the disease has been further understanding of the disease. This article reviews some of the foreign literature in this area for clinical reference. First, the steroid-induced high intraocular pressure response: the authors are mostly 0.1% betamethasone (Betamethasone) or 0.1% dexamethasone (dexamethasone) solution, 4 times daily eye drops observed for 2 weeks to about February, such as the eye Pressure increased to 20mmHg above, or higher than the drug before treatment 5mmHg are known as intraocular pressure steroid-positive reaction. The primary open-angle glaucoma, Armaly et al reported that almost all cases were positive, this ocular hypertension without